Thomas V. Bilfinger

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Presence of the μ3 Opiate Receptor in Endothelial Cells

George B. Stefano, Alan Hartman, Thomas V. Bilfinger et al. · Journal of Biological Chemistry · 1995 · 277 citations · Full text

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis

Ron Waksman, Toby Rogers, Rebecca Torguson et al. · Journal of the American College of Cardiology · 2018 · 227 citations

Cardiovascular Disease, Vascular Surgery, Low-risk Patients +7

Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression.

George B. Stefano, A. Digenis, S. Spector et al. · Proceedings of the National Academy of Sciences · 1993 · 211 citations · Full text

Opiate-like Substances, Immunology, Pharmacotherapy +21

Comparison of Survival after Sublobar Resections and Ablative Therapies for Stage I Non−Small Cell Lung Cancer

Alla Zemlyak, William H. Moore, Thomas V. Bilfinger · Journal of the American College of Surgeons · 2010 · 183 citations